title: Long-term zidovudine responders: is there still rationale for HIV monotherapy?
authors.forename: V
authors.initials: V
authors.lastname: Soriano
authors.forename: A
authors.initials: A
authors.lastname: Mas
authors.forename: A
authors.initials: A
authors.lastname: Heredia
authors.forename: A
authors.initials: A
authors.lastname: Vallejo
authors.forename: I
authors.initials: I
authors.lastname: Hewlett
authors.forename: J
authors.initials: J
authors.lastname: Epstein
authors.forename: J
authors.initials: J
authors.lastname: González-Lahoz
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use*; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1; D006801:Humans; D013997:Time Factors; D015215:Zidovudine / Q000627:therapeutic use*
chemical_list: D019380:Anti-HIV Agents; D015215:Zidovudine